7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Role of Sigma Receptors in Alcohol Addiction

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pharmacological treatments for alcohol use disorder (AUD) are few in number and often ineffective, despite the significant research carried out so far to better comprehend the neurochemical underpinnings of the disease. Hence, research has been directed towards the discovery of novel therapeutic targets for the treatment of AUD. In the last decade, the sigma receptor system has been proposed as a potential mediator of alcohol reward and reinforcement. Preclinical studies have shown that the motivational effects of alcohol and excessive ethanol consumption involve the recruitment of the sigma receptor system. Furthermore, sigma receptor antagonism has been shown to be sufficient to inhibit many behaviors related to AUDs. This paper will review the most current evidence in support of this receptor system as a potential target for the development of pharmacological agents for the treatment of alcohol addiction.

          Related collections

          Most cited references61

          • Record: found
          • Abstract: found
          • Article: not found

          Sex and gender-related differences in alcohol use and its consequences: Contemporary knowledge and future research considerations.

          To review the contemporary evidence reflecting male/female differences in alcohol use and its consequences along with the biological (sex-related) and psycho-socio-cultural (gender-related) factors associated with those differences.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Progressive ratio as a measure of reward strength.

            W Hodos (1961)
            Four rats were trained to press a lever on a ratio schedule of reinforcement in which the number of lever presses required on each consecutive run increased by a fixed increment. Both concentration and volume of the reward were varied. Relationships were obtained between reward and deprivation variables and the size of the final completed ratio run.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Crystal structure of the human σ1 receptor.

              The human σ1 receptor is an enigmatic endoplasmic-reticulum-resident transmembrane protein implicated in a variety of disorders including depression, drug addiction, and neuropathic pain. Recently, an additional connection to amyotrophic lateral sclerosis has emerged from studies of human genetics and mouse models. Unlike many transmembrane receptors that belong to large, extensively studied families such as G-protein-coupled receptors or ligand-gated ion channels, the σ1 receptor is an evolutionary isolate with no discernible similarity to any other human protein. Despite its increasingly clear importance in human physiology and disease, the molecular architecture of the σ1 receptor and its regulation by drug-like compounds remain poorly defined. Here we report crystal structures of the human σ1 receptor in complex with two chemically divergent ligands, PD144418 and 4-IBP. The structures reveal a trimeric architecture with a single transmembrane domain in each protomer. The carboxy-terminal domain of the receptor shows an extensive flat, hydrophobic membrane-proximal surface, suggesting an intimate association with the cytosolic surface of the endoplasmic reticulum membrane in cells. This domain includes a cupin-like β-barrel with the ligand-binding site buried at its centre. This large, hydrophobic ligand-binding cavity shows remarkable plasticity in ligand recognition, binding the two ligands in similar positions despite dissimilar chemical structures. Taken together, these results reveal the overall architecture, oligomerization state, and molecular basis for ligand recognition by this important but poorly understood protein.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Pharmacol
                Front Pharmacol
                Front. Pharmacol.
                Frontiers in Pharmacology
                Frontiers Media S.A.
                1663-9812
                14 June 2019
                2019
                : 10
                : 687
                Affiliations
                [1]Laboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry, Boston University School of Medicine , Boston, MA, United States
                Author notes

                Edited by: Ebru Aydar, University College London, United Kingdom

                Reviewed by: Elena Martín-García, Universidad Pompeu Fabra, Spain; Carlo Cifani, University of Camerino, Italy; Sheketha R. Hauser, Indiana University Bloomington, United States

                *Correspondence: Valentina Sabino, vsabino@ 123456bu.edu

                This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology

                Article
                10.3389/fphar.2019.00687
                6586921
                31258483
                cf4124f5-b3f6-4d2d-b422-850d14f29d99
                Copyright © 2019 Quadir, Cottone and Sabino

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 08 February 2019
                : 27 May 2019
                Page count
                Figures: 0, Tables: 2, Equations: 0, References: 68, Pages: 7, Words: 4184
                Funding
                Funded by: National Institute on Alcohol Abuse and Alcoholism 10.13039/100000027
                Funded by: National Institute on Alcohol Abuse and Alcoholism 10.13039/100000027
                Funded by: National Institute on Alcohol Abuse and Alcoholism 10.13039/100000027
                Categories
                Pharmacology
                Review

                Pharmacology & Pharmaceutical medicine
                alcoholism,drinking,dependence,ethanol,consumption
                Pharmacology & Pharmaceutical medicine
                alcoholism, drinking, dependence, ethanol, consumption

                Comments

                Comment on this article